“The value of an accreditation from CAP cannot be overstated for strengthening our positioning within our scientific community, as well as the business community and investors."
SAN FRANCISCO (PRWEB) December 01, 2020
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to IDbyDNA Inc., the company revolutionizing the use of metagenomics to improve health by decoding the unknown, based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.
The facility’s director, Robert Schlaberg, MD, PhD, MPH, was advised of this national recognition and congratulated for the excellence of the services being provided. IDbyDNA is one of more than 8,000 CAP-accredited facilities worldwide.
“This recognition further demonstrates our commitment to the highest levels of metagenomic testing,” said Dr. Schlaberg. “To be recognized for our excellence by the world’s largest organization of board-certified pathologists serves as another confirmation that we’re not only advancing our field with great work, but we’re also doing it the right way.”
IDbyDNA’s Chief Executive Officer, Guochun Liao, PhD, MBA, added, “The value of an accreditation from CAP cannot be overstated for strengthening our positioning within our scientific community, as well as the business community and investors. Third-party validation is of the utmost importance in the scientific community and we’re honored to receive it from CAP.”
The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal-to or more-stringent-than the government’s own inspection program.
During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory’s records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.
IDbyDNA is revolutionizing the use of clinical metagenomics to improve health by decoding the unknown. IDbyDNA’s product suite delivers unparalleled data analytics and industry-leading expertise to support medical laboratories with actionable infectious disease testing and pathogen surveillance. By profiling tens of thousands of microorganisms from any specimen with a scalable and intuitive approach, IDbyDNA empowers healthcare providers with greater depth and transparency for better identification of pathogens in order to accelerate triage and treatment and improve public health. For more information, visit http://www.idbydna.com or reach out to us on Twitter, Facebook, LinkedIn, Vimeo or YouTube.
About the College of American Pathologists
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP Annual Report at cap.org.